Sumi Misa, Ichikawa Yoko, Nakamura Takashi
Department of Radiology and Cancer Biology, Nagasaki University School of Dentistry, Nagasaki, Japan.
Eur Radiol. 2007 Oct;17(10):2631-7. doi: 10.1007/s00330-007-0588-z. Epub 2007 Feb 16.
We evaluated the diagnostic ability of diffusion-weighted imaging for the differentiation between lymphomas and carcinomas in the pharynx and between carcinomas with different histological types in the pharynx. T1-weighted, fat-suppressed T2-weighted, and diffusion-weighted MR imaging was performed on 14 patients with pharyngeal lymphomas, 26 patients with carcinomas of the pharynx, 5 patients with adenoidal hypertrophy, and 22 patients with normal tonsils. Apparent diffusion coefficients (ADCs) were determined by using two b factors (500 and 1,000 s/mm(2)). The ADCs of lymphomas were significantly smaller (0.454 +/- 0.075 x 10(-3) mm(2)/s) than those of carcinomas (0.863 +/- 0.238 x 10(-3) mm(2)/s). The ADCs of poorly differentiated and undifferentiated carcinomas (0.691 +/- 0.149 x 10(-3) mm(2)/s) were significantly smaller than those of moderately differentiated and well-differentiated carcinomas (0.971 +/- 0.221 x 10(-3) mm(2)/s), but were significantly larger than those of lymphomas. When an ADC smaller than 0.560 x 10(-3) mm(2)/s was used for predicting lymphomas, we obtained the highest accuracy of 96%, with 100% sensitivity and 94% specificity, 86% positive predictive value, and 100% negative predictive value. Therefore, ADC measurements effectively differentiate lymphomas from carcinomas in the pharynx and could be a useful adjunct to biopsy-based development of treatment planning.
我们评估了扩散加权成像在鉴别咽部淋巴瘤与癌以及不同组织学类型的咽部癌方面的诊断能力。对14例咽部淋巴瘤患者、26例咽部癌患者、5例腺样体肥大患者和22例正常扁桃体患者进行了T1加权、脂肪抑制T2加权和扩散加权磁共振成像。使用两个b值(500和1000 s/mm²)测定表观扩散系数(ADC)。淋巴瘤的ADC(0.454±0.075×10⁻³ mm²/s)显著低于癌(0.863±0.238×10⁻³ mm²/s)。低分化和未分化癌的ADC(0.691±0.149×10⁻³ mm²/s)显著低于中分化和高分化癌(0.971±0.221×10⁻³ mm²/s),但显著高于淋巴瘤。当使用小于0.560×10⁻³ mm²/s的ADC来预测淋巴瘤时,我们获得了最高96%的准确率,敏感性为100%,特异性为94%,阳性预测值为86%,阴性预测值为100%。因此,ADC测量可有效鉴别咽部淋巴瘤与癌,并且可能是基于活检制定治疗计划的有用辅助手段。